Core Laboratories Inc. $CLB Shares Purchased by UBS Group AG

UBS Group AG lifted its stake in Core Laboratories Inc. (NYSE:CLB) by 32.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 412,515 shares of the oil and gas company’s stock after purchasing an additional 102,151 shares during the quarter. UBS Group AG owned about 0.89% of Core Laboratories worth $6,613,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. CWM LLC increased its holdings in shares of Core Laboratories by 36.1% in the fourth quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock valued at $40,000 after purchasing an additional 668 shares during the last quarter. Quarry LP increased its stake in Core Laboratories by 118.1% during the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after acquiring an additional 1,599 shares during the last quarter. GAMMA Investing LLC increased its stake in Core Laboratories by 73.3% during the fourth quarter. GAMMA Investing LLC now owns 5,157 shares of the oil and gas company’s stock worth $83,000 after acquiring an additional 2,181 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in Core Laboratories by 400.9% during the second quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock worth $84,000 after acquiring an additional 5,869 shares during the last quarter. Finally, Vestcor Inc acquired a new stake in Core Laboratories during the third quarter worth $101,000. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Stock Up 1.1%

Core Laboratories stock opened at $13.72 on Wednesday. Core Laboratories Inc. has a 1-year low of $9.72 and a 1-year high of $20.36. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.05 and a quick ratio of 1.50. The stock has a market cap of $632.26 million, a PE ratio of 21.10, a P/E/G ratio of 2.69 and a beta of 0.99. The stock’s fifty day moving average is $15.83 and its two-hundred day moving average is $16.71.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.06. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.The company had revenue of $121.80 million for the quarter, compared to analysts’ expectations of $122.99 million. During the same period last year, the firm earned $0.14 earnings per share. Core Laboratories’s quarterly revenue was down 1.4% on a year-over-year basis. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. On average, sell-side analysts expect that Core Laboratories Inc. will post 0.54 EPS for the current fiscal year.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Monday, May 11th will be given a dividend of $0.01 per share. The ex-dividend date is Monday, May 11th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. Core Laboratories’s payout ratio is 6.15%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Weiss Ratings cut Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 4th. Wall Street Zen raised Core Laboratories from a “sell” rating to a “hold” rating in a research note on Sunday. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Core Laboratories has a consensus rating of “Hold” and an average target price of $12.00.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.